Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed6
Other1

Role Distribution

Principal Investigator6
Other Roles1
PI Rate86%

Activity Timeline

Clinical Trials (7)

NCT04283539Completed
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
CancerImmunotherapyPatients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control+1 more
PrincipalinvestigatorStart date: 2020-09-23
NCT00822276Completed
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)
Atopic DermatitisEczema HerpeticumMethicillin-Resistant Staphylococcus Aureus+1 more
Principalinvestigator
NCT01518478Early Phase 1Completed
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot
Atopic Dermatitis
Principalinvestigator
NCT01737710Not ApplicableCompleted
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study
Dermatitis, Atopic
Studychair
NCT01950494Not ApplicableCompleted
FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults
Hand Dermatitis
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Richard Gallo, MD, PhD

University of California, San Diego

Moderately Similar
4 trials

Shared therapeutic areas:

Dermatitis, AtopicEczema HerpeticumMethicillin-Resistant Staphylococcus aureus

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Gloria David, PhD, MHSc

Rho, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Dermatitis, AtopicEczema HerpeticumMethicillin-Resistant Staphylococcus aureus

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Patrick Schlievert, PhD

University of Minnesota

Moderately Similar
1 trials

Shared therapeutic areas:

Dermatitis, AtopicEczema HerpeticumMethicillin-Resistant Staphylococcus aureus

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Nichole Reisdorph, PhD, MS

National Jewish Health

Moderately Similar
1 trials

Shared therapeutic areas:

Dermatitis, AtopicEczema HerpeticumMethicillin-Resistant Staphylococcus aureus

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score34%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

Xinghua Gao

First Hospital of China Medical University

Related
5 trials

Shared therapeutic areas:

Dermatitis, Atopic
Similarity Score4%

Emily Y Chew, M.D.

National Eye Institute (NEI)

Related
17 trials

Shared therapeutic areas:

Cancer
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT04283539PrincipalInvestigator

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

CancerImmunotherapyPatients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control+1 more
Completed
NCT00407069PrincipalInvestigator

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

Atopic Dermatitis
Completed
NCT00822276PrincipalInvestigator

The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)

Atopic DermatitisEczema HerpeticumMethicillin-Resistant Staphylococcus Aureus+1 more
Completed
NCT01518478Early Phase 1PrincipalInvestigator

Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot

Atopic Dermatitis
Completed
NCT01737710Not ApplicableStudyChair

Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study

Dermatitis, Atopic
Completed
NCT01950494Not ApplicablePrincipalInvestigator

FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults

Hand Dermatitis
Completed
NCT02680405PrincipalInvestigator

Identification of Epidermal Signatures in Patients With Atopic Dermatitis

Atopic Dermatitis
Unknown

All 7 trials loaded